Search Results - "Ito, Jasmine"

Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner by Batsuli, Glaivy, Ito, Jasmine, York, Elizabeth S., Cox, Courtney, Baldwin, Wallace, Gill, Surinder, Lollar, Pete, Meeks, Shannon L.

“…Introduction Soluble antigens complexed with immunoglobulin G (IgG) antibodies can induce robust adaptive immune responses in vitro and in animal models of…”
Get full text

Investigating persistent factor VIII-specific IgM in the humoral immune response to factor VIII by York, Elizabeth S, Ito, Jasmine, Batsuli, Glaivy

“…Abstract Hemophilia A is an X-linked bleeding disorder resulting in bleeding events due to insufficient levels of factor VIII (FVIII). The most significant…”
Get full text

Persistent Splenic-Derived IgM Preferentially Recognize Factor VIIIA2 and C2 Domain Epitopes but Do Not Alter Antibody Production by York, Elizabeth S, Dratch, Benjamin D, Ito, Jasmine, Horwitz, Samantha M, Emamian, Sahand, Ambarian, Joseph A, Gill, Surinder, Jones, Jayre, Chonat, Satheesh, Lollar, Pete, Meeks, Shannon L, Davis, Katherine M, Batsuli, Glaivy

“…The most significant treatment complication for patients with hemophilia A is the development of neutralizing immunoglobin G (IgG), termed inhibitors, against…”
Get full text

Removal of single‐site N‐linked glycans on factor VIII alters binding of domain‐specific monoclonal antibodies by Ito, Jasmine, Baldwin, Wallace Hunter, Cox, Courtney, Healey, John F., Parker, Ernest T., Legan, Emily R., Li, Renhao, Gill, Surinder, Batsuli, Glaivy

“…Background A portion of individuals with hemophilia A develop neutralizing antibodies called inhibitors to glycoprotein factor VIII (FVIII). There are multiple…”
Get full text

The Impact of Anti-Factor VIII A1 and A3 Domain Antibodies in the Immune Reponse to Factor VIII in Patients with Hemophilia a by Ito, Jasmine C, Cox, Courtney, Baldwin, W. Hunter, Doering, Christopher B, Meeks, Shannon L.

“…Introduction: Up to 30% of treated patients with severe hemophilia A will develop inhibitory antibodies to factor VIII (fVIII inhibitors). These patients…”
Get full text

Very High Dose Factor VIII Needed to Prevent Bleeding in the Presence of a Low Titer Anti-C1 Domain Antibody by Ito, Jasmine, Mercer, Rylee, Baldwin, Wallace Hunter, Batsuli, Glaivy, Meeks, Shannon L.

“…Introduction: Up to 30% of patients with severe hemophilia A will develop inhibitory antibodies to factor VIII (fVIII inhibitors). Patients with congenital…”
Get full text